Swaroop Pharmaceuticals Private Limited, a active private limited company, was established on 08 May 1998 in Uttar Pradesh, Uttar Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231UP1998PTC023440. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.00 Cr.
It upholds a compliant status. Employing 18 professional, Its leadership includes Vineet Kela (Director), Puneet Kela (Director), Atul Agrawal (Director). It holds ₹12.00 Cr open charges and ₹15.81 Cr settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Ram Kutir Kela Nagar Aligarh, Uttar Pradesh, Uttar Pradesh, 202001.
U24231UP1998PTC023440
023440
08 May 1998
₹5.00 Cr
₹4.00 Cr
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Swaroop Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vineet Kela | Director | 08 May 1998 | Current |
| Puneet Kela | Director | 08 May 1998 | Current |
| Atul Agrawal | Director | 31 Mar 2008 | Current |
| Sanjay Maheshwari | Director | 08 May 1998 | Current |
| Vijay Maheshwari | Director | 08 May 1998 | Current |
| Jaiprakash Agarwal | Director | 31 Mar 2008 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Swaroop Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 55.84% increase. The company also saw a substantial improvement in profitability, with a 274.71% increase in profit. The company's net worth Soared by an impressive increase of 16.54%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Swaroop Pharmaceuticals had a promoter holding of 71.52% and a public holding of 28.48%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹120,000,000.00
₹158,119,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Dec 2024 | Others | ₹12.00 Cr | Open |
| 30 Jul 2020 | Others | ₹6.50 M | Satisfied |
| 30 Jul 2020 | Others | ₹1.30 Cr | Satisfied |
| 16 Mar 2012 | Bank Of Baroda | ₹9.90 Cr | Satisfied |
| 17 Sep 2008 | Bank Of India | ₹3.96 Cr | Satisfied |
Explore comprehensive loan charge details -
Swaroop Pharmaceuticals has a workforce of 18 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Swaroop Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Swaroop Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
A charge registered on 30 Jul 2020 via Charge ID 100367699 with Others was fully satisfied on 15 Jan 2025. was recorded as a recent event.
The activity A charge registered on 30 Jul 2020 via Charge ID 100367710 with Others was fully satisfied on 15 Jan 2025. was completed.
A charge registered on 16 Mar 2012 via Charge ID 10344602 with Bank Of Baroda was fully satisfied on 15 Jan 2025. was recorded as a recent event.
The activity A charge with Others amounted to Rs. 12.00 Cr with Charge ID 101029410 was registered on 18 Dec 2024. was completed.
Progress on Swaroop Pharmaceuticals Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.
Swaroop Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
The CIN of Swaroop Pharmaceuticals Private Limited is U24231UP1998PTC023440.
Swaroop Pharmaceuticals Private Limited is headquartered at Ram Kutir Kela Nagar Aligarh, Uttar Pradesh, Uttar Pradesh, 202001.
Swaroop Pharmaceuticals Private Limited was incorporated on 08 May 1998.
The current directors of Swaroop Pharmaceuticals Private Limited are
The primary industry of Swaroop Pharmaceuticals Private Limited is Manufacturing.
Swaroop Pharmaceuticals Private Limited is unlisted.
The authorized capital of Swaroop Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹4.00 Cr.
The compliance status of Swaroop Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX